MetaCap

Immutep (IMMP) News

NASDAQ: IMMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.11-0.31 (-9.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IMMP news summary

We found 12 recent headlines mentioning Immutep (IMMP): 3 in the past week and 9 in the past 30 days, most often from GlobeNewswire, Nasdaq. IMMP is making an outsized move today, down 9.06% at $3.11, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Immutep Limited Reports 81.1% 12-month Disease-Free Survival in EFTISARC-NEO Phase II Trial", was published by Nasdaq on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Immutep headlines

Stocks mentioned alongside IMMP

Compare IMMP